, Volume 66, Issue 14, pp 1797–1806

Antistaphylococcal Vaccines and Immunoglobulins

Current Status and Future Prospects
Leading Article

DOI: 10.2165/00003495-200666140-00002

Cite this article as:
Deresinski, S. Drugs (2006) 66: 1797. doi:10.2165/00003495-200666140-00002


Staphylococci are among the most frequently encountered pathogens in both the inpatient and the outpatient setting. Management of infections caused by these organisms is complicated by the increasingly common resistance of staphylococcal pathogens to commonly used antibacterials. As a consequence, novel approaches to prevention and treatment are urgently required. Such approaches include the development of vaccines and immunoglobulin preparations targeted at virulence factors expressed in vivo by staphylococci. This article reviews the biopharmaceutical progress made to date in this field and suggests approaches to further progress.

Copyright information

© Adis Data Information BV 2006

Authors and Affiliations

  1. 1.Stanford UniversityStanfordUSA
  2. 2.Santa Clara Valley Medical CenterSan JoseUSA
  3. 3.Redwood CityUSA

Personalised recommendations